共 50 条
- [11] ESTROGEN RECEPTORS (ER) AND CHEMOTHERAPY(CT) IN BREAST-CANCER PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 367 - 367
- [12] SYSTEMIC (S) CHEMOTHERAPY (CT) VS LOCORREGIONAL (LR) TREATMENT FOR BREAST-CANCER PATIENTS (BCP) WITH LIVER METASTASES PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 175 - 175
- [13] NIMORAZOLE (NIMO) PLUS CHEMOTHERAPY (CT) IN ADVANCED CANCER-PATIENTS (PT) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 178 - 178
- [15] HIGH-DOSE PARENTERAL MEDROXIPROGESTERONE ACETATE (MPA) PREVENTS GRANULOCYTOPENIA FROM FAC CHEMOTHERAPY (CT) IN ADVANCED BREAST-CANCER (BC) PATIENTS (PT) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 196 - 196
- [18] VELBAN (V) INFUSION WITH COMBINATION CHEMOTHERAPY (CT) AS PRIMARY CT OF METASTATIC BREAST-CANCER PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 444 - 444